Orexo Financial Statements From 2010 to 2024
| ORX Stock | SEK 12.28 1.92 18.53% |
Check Orexo AB financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Orexo AB's main balance sheet or income statement drivers, such as , as well as many indicators such as . Orexo financial statements analysis is a perfect complement when working with Orexo AB Valuation or Volatility modules.
Orexo |
Orexo AB Company Return On Equity Analysis
Orexo AB's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Orexo AB Return On Equity | -0.65 |
Most of Orexo AB's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Orexo AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Orexo AB has a Return On Equity of -0.6535. This is 97.27% lower than that of the Pharmaceuticals sector and 286.71% lower than that of the Health Care industry. The return on equity for all Sweden stocks is 110.81% higher than that of the company.
Orexo AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Orexo AB's current stock value. Our valuation model uses many indicators to compare Orexo AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Orexo AB competition to find correlations between indicators driving Orexo AB's intrinsic value. More Info.Orexo AB is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Orexo AB's earnings, one of the primary drivers of an investment's value.About Orexo AB Financial Statements
Orexo AB shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Orexo AB investors may analyze each financial statement separately, they are all interrelated. The changes in Orexo AB's assets and liabilities, for example, are also reflected in the revenues and expenses on on Orexo AB's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Orexo AB , a specialty pharmaceutical company, develops products based on proprietary drug delivery technology. Orexo AB was founded in 1995 and is headquartered in Uppsala, Sweden. Orexo AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 130 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Orexo Stock Analysis
When running Orexo AB's price analysis, check to measure Orexo AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orexo AB is operating at the current time. Most of Orexo AB's value examination focuses on studying past and present price action to predict the probability of Orexo AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orexo AB's price. Additionally, you may evaluate how the addition of Orexo AB to your portfolios can decrease your overall portfolio volatility.